These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1452367

  • 1. A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.
    Mountzouros KT, Kimura A, Cowell JL.
    Infect Immun; 1992 Dec; 60(12):5316-8. PubMed ID: 1452367
    [Abstract] [Full Text] [Related]

  • 2. Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.
    Shahin RD, Hamel J, Leef MF, Brodeur BR.
    Infect Immun; 1994 Feb; 62(2):722-5. PubMed ID: 8300232
    [Abstract] [Full Text] [Related]

  • 3. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL.
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [Abstract] [Full Text] [Related]

  • 4. Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.
    Martin D, Peppler MS, Brodeur BR.
    Infect Immun; 1992 Jul; 60(7):2718-25. PubMed ID: 1377181
    [Abstract] [Full Text] [Related]

  • 5. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.
    Brodeur BR, Martin D, Hamel J, Shahin RD, Laferrière C.
    Springer Semin Immunopathol; 1993 Jul; 15(2-3):205-15. PubMed ID: 8256198
    [No Abstract] [Full Text] [Related]

  • 6. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H, Sato Y.
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [Abstract] [Full Text] [Related]

  • 7. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.
    Trollfors B, Lagergård T, Taranger J, Bergfors E, Schneerson R, Robbins JB.
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):1015-7. PubMed ID: 11527820
    [Abstract] [Full Text] [Related]

  • 8. Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A.
    Archambault D, Rondeau P, Martin D, Brodeur BR.
    J Gen Microbiol; 1991 Apr; 137(4):905-11. PubMed ID: 1713258
    [Abstract] [Full Text] [Related]

  • 9. Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization.
    Errea A, Moreno G, Sisti F, Fernández J, Rumbo M, Hozbor DF.
    Med Microbiol Immunol; 2010 May; 199(2):103-8. PubMed ID: 20143087
    [Abstract] [Full Text] [Related]

  • 10. Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.
    Li ZM, Cowell JL, Brennan MJ, Burns DL, Manclark CR.
    Infect Immun; 1988 Mar; 56(3):699-702. PubMed ID: 2893776
    [Abstract] [Full Text] [Related]

  • 11. Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide.
    Brodeur BR, Hamel J, Martin D, Rondeau P.
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):194-9. PubMed ID: 1721552
    [Abstract] [Full Text] [Related]

  • 12. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET.
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [Abstract] [Full Text] [Related]

  • 13. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH, Artamonova GV, Andreasen C, Dudley E, Mays RM, Worthington ZE.
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [Abstract] [Full Text] [Related]

  • 14. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 15. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
    Geurtsen J, Fae KC, van den Dobbelsteen GP.
    Expert Rev Vaccines; 2014 Oct 08; 13(10):1229-40. PubMed ID: 25081731
    [Abstract] [Full Text] [Related]

  • 16. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R, Daggard G, Mukkur T.
    J Microbiol Biotechnol; 2012 Jun 08; 22(6):856-65. PubMed ID: 22573165
    [Abstract] [Full Text] [Related]

  • 17. [Bordetella pertussis lipooligosaccharide-derived neoglycoconjugates - new components of pertussis vaccine].
    Koj S, Ługowski C, Niedziela T.
    Postepy Hig Med Dosw (Online); 2015 Sep 08; 69():1013-30. PubMed ID: 26400888
    [Abstract] [Full Text] [Related]

  • 18. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.
    Harvill ET, Preston A, Cotter PA, Allen AG, Maskell DJ, Miller JF.
    Infect Immun; 2000 Dec 08; 68(12):6720-8. PubMed ID: 11083787
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H, Ito A, Chiba J, Sato Y.
    Infect Immun; 1984 Nov 08; 46(2):422-8. PubMed ID: 6094351
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M, Cropley I, Chatfield S, Dougan G.
    Vaccine; 1993 Nov 08; 11(8):866-72. PubMed ID: 8356847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.